Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H20N2O3S |
InChIKeyDFTITSOGUUDLJM-UVTDQMKNSA-N |
CAS Registry202920-57-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 14 Jul 1997 |





